Omega Healthcare Investors, Inc. (OHI) Financial Statements

Executive TeamFinancials
Shareholders

Omega Healthcare Investors financial statements at a glance

Omega Healthcare Investors reported revenue of $1.19 billion for fiscal year 2025 (ended December 31, 2025), up 13.2% from fiscal year 2024. Net income was $572.03 million, a net margin of 48.1%, and diluted earnings per share were $1.94.

At the end of fiscal year 2025 it had total assets of $10.05 billion, total liabilities of $4.61 billion and shareholders' equity of $5.18 billion, with cash and short-term investments of $27.02 million and total debt of $4.26 billion.

Its operations brought in $878.55 million of cash, leaving free cash flow of $878.55 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

OHI logo

Omega Healthcare Investors, Inc.

OHIUnited States
Financial Services
USD (Local)

Income Statement

Annual • USD

Total Revenue
1.19B
Prev Year: 1.05B
YoY: +13.2%
Operating Revenue
1.18B
Prev Year: 1.05B
YoY: +12.6%
Total Unusual Items
45.47M
Prev Year: -24.03M
YoY: +289.2%
Normalized EBITDA
1.12B
Prev Year: 971.14M
YoY: +15.3%
Tax Rate for Calcs
0.024
Prev Year: 0
Tax Effect of Unusual Items
1.07M
Prev Year: -620.0K
YoY: +273.2%
Average Dilution Earnings
19.36M
Prev Year: 12.06M
YoY: +60.5%
Otherunder Preferred Stock Dividend
18.16M
Equity in Earnings of Affiliates, Net of Tax
-218.0K
Prev Year: 7.92M
YoY: -102.8%
Gain on Sale of Property, Plant and Equipment
67.30M
Prev Year: 13.17M
YoY: +411.1%
Other Special Charges
-5.00M
Prev Year: 1.75M
YoY: -385.6%
Provision for Doubtful Accounts
2.34M
Prev Year: -15.48M
YoY: +115.1%
Cost of Revenue
14.44M
Prev Year: 14.56M
YoY: -0.8%
Gross Profit
1.18B
Prev Year: 1.04B
YoY: +13.4%
Operating Expense
431.72M
Prev Year: 377.17M
YoY: +14.5%
Selling General and Administrative
104.14M
Prev Year: 88.00M
YoY: +18.3%
General and Administrative Expense
104.14M
Prev Year: 88.00M
YoY: +18.3%
Other General and Administrative
104.14M
Prev Year: 88.00M
YoY: +18.3%
Depreciation Amortization Depletion
325.25M
Prev Year: 304.65M
YoY: +6.8%
Depreciation and amortization
325.25M
Prev Year: 304.65M
YoY: +6.8%
Operating Income
743.94M
Prev Year: 659.66M
YoY: +12.8%
Net Non Operating Interest Income Expense
-215.03M
Prev Year: -221.72M
YoY: +3.0%
Non-operating Interest Expense
215.03M
Prev Year: 221.72M
YoY: -3.0%
Non-operating Interest Income
-
Other Income Expense
95.53M
Prev Year: -17.20M
YoY: +655.4%
Special Income Charges
45.47M
Prev Year: -24.03M
YoY: +289.2%
Gain on Sale of Securities
-
Restructuring and Mergers Acquisition
4.22M
Prev Year: 11.62M
YoY: -63.7%
Impairment of Capital Assets
22.61M
Prev Year: 23.83M
YoY: -5.1%
Other Non-operating Income (expense)
50.06M
Prev Year: 6.83M
YoY: +633.3%
Pre-tax Income
624.43M
Prev Year: 420.75M
YoY: +48.4%
Provision for Income Taxes
14.75M
Prev Year: 10.86M
YoY: +35.8%
Net Income Common Stockholders
572.03M
Prev Year: 406.33M
YoY: +40.8%
Net Income
590.18M
Prev Year: 406.33M
YoY: +45.2%
Net Income Including Non-Controlling Interests
609.47M
Prev Year: 417.80M
YoY: +45.9%
Net Income from Continuing Operations
609.47M
Prev Year: 417.80M
YoY: +45.9%
Noncontrolling Interests
-19.28M
Prev Year: -11.48M
YoY: -68.0%
Diluted NI Available to Com Stockholders
591.39M
Prev Year: 418.39M
YoY: +41.3%
Basic EPS
1.96
Prev Year: 1.57
YoY: +24.8%
Diluted EPS
1.94
Prev Year: 1.55
YoY: +25.2%
Weighted Average Shares (basic)
291.65M
Prev Year: 258.12M
YoY: +13.0%
Weighted Average Shares (diluted)
304.95M
Prev Year: 270.45M
YoY: +12.8%
Total Expenses
446.16M
Prev Year: 391.73M
YoY: +13.9%
Net Income from Continuing and Discontinued Operation
590.18M
Prev Year: 406.33M
YoY: +45.2%
Total Operating Income as Reported
-
Normalized Income
545.79M
Prev Year: 429.73M
YoY: +27.0%
Interest Expense
215.03M
Prev Year: 221.72M
YoY: -3.0%
Net Interest Income
-215.03M
Prev Year: -221.72M
YoY: +3.0%
EBIT
839.47M
Prev Year: 642.46M
YoY: +30.7%
Interest Income
-
EBITDA
1.16B
Prev Year: 947.11M
YoY: +23.0%
Reconciled Cost of Revenue
14.44M
Prev Year: 14.56M
YoY: -0.8%
Reconciled Depreciation
325.25M
Prev Year: 304.65M
YoY: +6.8%
Net Income from Continuing Operation Net Minority Interest
590.18M
Prev Year: 406.33M
YoY: +45.2%
Total Unusual Items Excluding Goodwill
45.47M
Prev Year: -24.03M
YoY: +289.2%
Values in USD

Omega Healthcare Investors key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$1.2B$1.1B$949.7M$878.2M$1.1B
Gross profit$1.2B$1.0B$934.7M$862.7M$1.1B
Operating income$743.9M$659.7M$489.0M$392.3M$566.2M
Net income$572.0M$406.3M$242.2M$426.9M$416.7M
Diluted EPS$1.94$1.55$1.00$1.80$1.75
Total assets$10.0B$9.9B$9.1B$9.4B$9.6B
Total liabilities$4.6B$5.2B$5.4B$5.6B$5.5B
Shareholders' equity$5.2B$4.5B$3.6B$3.6B$3.9B
Cash and short-term investments$27.0M$518.3M$442.8M$297.1M$20.5M
Total debt$4.3B$4.8B$5.1B$5.3B$5.3B
Operating cash flow$878.6M$749.4M$617.7M$625.7M$722.1M
Capital spending––––$95.1M
Free cash flow$878.6M$749.4M$617.7M$625.7M$722.1M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Omega Healthcare Investors's revenue in fiscal year 2025?

$1.19 billion, up 13.2% from $1.05 billion in fiscal year 2024.

How much profit does Omega Healthcare Investors make?

Omega Healthcare Investors reported net income of $572.03 million for fiscal year 2025 (48.1% of revenue); operating income was $743.94 million.

How much cash and debt does Omega Healthcare Investors have?

At the end of fiscal year 2025: cash and short-term investments of $27.02 million and total debt of $4.26 billion.

What is Omega Healthcare Investors's free cash flow?

$878.55 million in fiscal year 2025 (operating cash flow of $878.55 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube